ஜெனிபர் தாழ்வான News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெனிபர் தாழ்வான. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெனிபர் தாழ்வான Today - Breaking & Trending Today

ASCO GU 2021: Clinical Outcomes of Patients With mCRPC Receiving Radium-223 Early Versus Late in the Treatment Sequence


SHARE
ASCO GU 2021: Clinical Outcomes of Patients With mCRPC Receiving Radium-223 Early Versus Late in the Treatment Sequence
Published 11 February 2021
(UroToday.com) Data from the landmark ALSYMPCA trial
1 found that the targeted alpha therapy Radium-223 prolonged overall survival in men with metastatic castration-resistant prostate cancer (mCRPC).
1 However, there is little data to guide clinicians as to the appropriate sequence for use of Radium-223 in men with mCRPC with regards to other life-prolonging therapies. At the 2021 ASCO Genitourinary Cancers Symposium (ASCO GU), Dr. Lawrence Mbuagbaw and colleagues presented results of their real-world study evaluating clinical outcomes of patients when Radium-223 was used early (second-line) or late (third or later lines) among men with mCRPC. ....

United States , Zachary Klaassen , Lawrence Mbuagbaw , Richardm Lee Ying , Jennifer Lowther , Mcmaster University , Ontario Institute For Clinical Evaluative Sciences , Augusta University Medical College Of Georgia , Bayer Inc , University Of Calgary , Georgia Cancer Center , Tom Baker Cancer Center , Cancers Symposium , Clinical Evaluative Sciences , Charlson Comorbidity Index , Urologic Oncologist , Assistant Professor , Medical College , ஒன்றுபட்டது மாநிலங்களில் , சக்கரி க்லாஸ்சேங் , ஜெனிபர் தாழ்வான , மக்மாஸ்டர் பல்கலைக்கழகம் , அகஸ்டா பல்கலைக்கழகம் மருத்துவ கல்லூரி ஆஃப் ஜார்ஜியா , பேயர் இன்க் , பல்கலைக்கழகம் ஆஃப் கல்கரி , ஜார்ஜியா புற்றுநோய் மையம் ,